SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-104055
Filing Date
2017-03-30
Accepted
2017-03-30 16:11:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d325403d424b5.htm 424B5 306213
2 GRAPHIC g325403g07o65.jpg GRAPHIC 12466
3 GRAPHIC g325403g73i65.jpg GRAPHIC 40193
  Complete submission text file 0001193125-17-104055.txt   379878
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-210224 | Film No.: 17725775
SIC: 2834 Pharmaceutical Preparations